@nepalcable51
actief 19 uren, 9 minuten geleden
Although erenumab has demonstrated significant reduction in migraine frequency and improved quality of life in studies lasting 3 to 12months, little is known about long-term therapy.
This study was an open-label, 5-year treatment phase following a 12-week, double-blind, placebo-controlled trial in adults with episodic migraine. Patients […] Bekijken
Sorry, er is geen activiteit gevonden. Probeer een ander filter.